Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Papillomavirus Infections 2Uterine Cervical Neoplasms 1HIV Infections 1Acquired Immunodeficiency Syndrome 1

Interventions

Etoposide 4Cyclophosphamide 4Vincristine 3Specimen Handling 3Prednisone 3Magnetic Resonance Spectroscopy 3Doxorubicin 3Biopsy 3fludarabine phosphate 2cabozantinib 2Whole-Body Irradiation 2Watchful Waiting 2Rituximab 2Polymerase Chain Reaction 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2Light Coagulation 2Imiquimod 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Gene Expression Profiling 2Fluorouracil 2technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1prednylidene 1pembrolizumab 1fludarabine 1emvododstat 1efineptakin alfa 1deltacortene 1carmustine, poliferprosan 20 drug combination 1Vorinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × HIV Infections × Electrocoagulation × Clear all
NCT04092257 2025-08-06

HPV-Based Screen-and-Treat Demonstration Project in Lilongwe

UNC Lineberger Comprehensive Cancer Center

Phase NA Completed
1,250 enrolled 12 charts
Gynecologic

Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡